Navigation Links
Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property
Date:6/29/2009

ders across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "project," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives a
'/>"/>

SOURCE Hill-Rom
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
3. Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... , - ... the Ability of,Cardiopoietic Cells to Restore Cardiac Function ... leading Belgian biotechnology company specialising,in cell-based therapies for ... has completed, two months ahead of schedule,enrolment in ... trial of C-Cure, a,unique stem cell therapy for ...
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ... collaboration with The Scripps Research Institute ("Scripps") by ... the genome of Dyadic,s patented and proprietary C1 ... of the successful relationship between the two organizations ... Scripps to annotate the C1 genome for the ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... visited Florida in mid-October. Late in the month, Florida Governor ... closed-door negotiations to create and pass a bill creating a ... Location for the Scripts Research Institute to focus on biotechnology ... is an example of a state that successfully attracted a ...
... MADISON, WI - Companies from nine different states staked ... and gave brief presentations in hopes of catching the ... Life Sciences & Venture Conference at Monona Terrace, Madison. ... the companies representing not only life sciences but ...
... in Wisconsin , , Editors Note: The ... NorthStar Economics 60-page report titled, the NorthStar Guide ... a primer for Wisconsin companies seeking information about risk capital ... agreed to excerpt their report in four-installments on WTN over ...
Other Biology Technology:Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies 2Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies 3Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies 4Investors Pick Favorites at Life Science Conference 2Investors Pick Favorites at Life Science Conference 3Community Development Venture Capital 2Community Development Venture Capital 3Community Development Venture Capital 4Community Development Venture Capital 5Community Development Venture Capital 6
(Date:12/15/2009)... Biotech, Inc. GenWay Clinical Laboratory, San Diego, California, ... of American Pathologists (CAP), based on results of ... laboratory,s director was advised of this national recognition ... being provided." GenWay Biotech Inc. GenWay Clinical Laboratory ... , The CAP Laboratory Accreditation Program, begun in ...
(Date:12/15/2009)... may have been grazing the North American steppe ... After plucking ancient DNA from frozen soil in ... techniques to uncover "genetic fossils" of both species ... and 10,500 calendar years. This new evidence suggests ... mammals endured longer in the continental interior, challenging ...
(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...
Breaking Biology News(10 mins):Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3Medicine wheel model for nutrition shows promise for control of type 2 diabetes 9854 1Medicine wheel model for nutrition shows promise for control of type 2 diabetes 9854 2Mayor Gavin Newsom to Be President Obamas Guest for Healthcare Reform Speech to the Nation 56678 1Mayor Gavin Newsom to Be President Obamas Guest for Healthcare Reform Speech to the Nation 56678 2Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 56676 1Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 56676 2
... the University of Bath are to be part of ... into safer, more effective anti-bacterial plastics and coatings that ... medical devices to wound dressings, and nappies. , The ... which have been shown to be highly effective against ...
... planet Mars has a moon named Deimos, so it ... Monterey Bay have its own DEIMOS. This DEIMOS, however, ... of fish and zooplankton. , MARS, which stands for ... size of two compact cars that serves as both ...
... is part of the healthy human intestinal flora. However, ... diarrhea illnesses: enterohemorrhagic E.coli bacteria. During the course ... in the process, in contrast to benign bacteria. , ... and alter them internally: a part of the cellular supportive ...
Other Biology News:University researchers to develop coatings that kill superbugs 2DEIMOS joins MARS and its satellite of instruments on seafloor 2DEIMOS joins MARS and its satellite of instruments on seafloor 3When intestinal bacteria go surfing 2
... The CopyControl™ vector can be induced ... These vectors provide the stability of single-copy ... cosmids or other cloning vectors. The kits ... (ligation reagents, insert size screening system) necessary ...
... 3T3 cells were cultured in DMEM with 4 ... of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on ... each wells surface specifically treated to enhance cellular ...
... vector can be induced prior to DNA ... the stability of single-copy BACs with the ... cloning vectors. The kits provide the linearized ... size screening system) necessary to create a ...
...
Biology Products: